References
- Cheng H, Chen C, Wang S, Ding G, Shi M. The effects of urokinase-type plasminogen activator (uPA) on cell proliferation and phenotypic transformation of rat mesangial cells induced by high glucose. Diabetes Res Clin Pract. 2014;103(3):489–495
- Ma LJ, Fogo AB. PAI-1 and kidney fibrosis. Front Biosci. 2009;14:2028–2041
- Nicholas SB, Aguiniga E, Ren Y, et al. Plasminogen activator inhibitor-1 deficiency retards diabetic nephropathy. Kidney Int. 2005;67(4):1297–1307
- Collins SJ, Alexander SL, Lopez-Guisa JM, et al. Plasminogen activator inhibitor-1 deficiency has renal benefits but some adverse systemic consequences in diabetic mice. Nephron Exp Nephrol. 2006;104:23–34
- Kenichi M, Masanobu M, Takehiko K, et al. Renal synthesis of urokinase type-plasminogen activator, its receptor, and plasminogen activator inhibitor-1 in diabetic nephropathy in rats: Modulation by angiotensin-converting-enzyme inhibitor. Jf Lab Clin Med 2004;144:69–77
- Zhang G, Eddy AA. Urokinase and its receptors in chronic kidney disease. Front Biosci. 2008;13:5462–5478
- Tada H, Tsukamoto M, Ishii H, et al. A high concentration of glucose alters the production of tPA, uPA and PAI-1 antigens from human mesangial cells. Diabetes Res Clin Pract. 1994;24:33–39
- Lupia E, Elliot SJ, Lenz O, et al. IGF-1 decreases collagen degradation in diabetic NOD mesangial cells: Implications for diabetic nephropathy. Diabetes. 1999;48:1638–1644
- Xi C, Chen X, Sun X, et al. Effects of alterations of glomerular fibrin deposition on renal inflammation in rats at different age stages. J Gerontol A Biol Sci Med Sci. 2005;60:1099–1110
- Cove-Smith A, Hendry BM. The regulation of mesangial cell proliferation. Nephron Exp Nephrol. 2008;108:74–79
- Awazu M, Omori S, Ishikura K, et al. The lack of cyclin kinase inhibitor p27Kip1 ameliorates progression of diabetic nephropathy. J Am Soc Nephrol. 2003;14:699–708
- Li Y, Knisely JM, Lu W, et al. Low density lipoprotein (LDL) receptor-related protein 1B impairs urokinase receptor regeneration on the cell surface and inhibits cell migration. J Biol Chem. 2002;277:42366–42371
- Zhang G, Kim H, Cai X, et al. Urokinase receptor modulates cellular and angiogenic responses in obstructive uropathy. J Am Soc Nephrol. 2003;14:1254–1271